# An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical Practice

> **NCT00576368** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 4464 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** INSULIN GLARGINE

## Key facts

- **NCT ID:** NCT00576368
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2004-04
- **Target enrollment:** 4464 (ACTUAL)
- **Last updated:** 2008-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00576368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00576368, "An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical Practice". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00576368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*